Miami Cardiac & Vascular Institute Grand Rounds: Evaluating and Treating Dyslipidemia in the Cardiometabolic Syndrome

Miami, FL US
February 15, 2017

Cardiometabolic syndrome is a constellation of metabolic dysfunction characterized by insulin resistance and impaired glucose tolerance, atherogenic dyslipidemia, hypertension and intra-abdominal adiposity (IAA). The components of this syndrome individually and interdependently are strong risk factors for high cardiovascular morbidity and mortality.  This course will provide an overview of the components of metabolic syndrome, as well as evidence-based recommendations for adequate management. 

Target Audience

Cardiologists, Endocrinologists, Family Physicians, General Internists, Psychologists, Physician Assistants, Nurse Practitioners, Nurses and Laboratory Personnel, Respiratory Therapists as well as other interested healthcare professionals.

Learning Objectives

  • Identify the components of the Metabolic Syndrome (MetS) and recognize the typical lipid profile in MetS.
  • Review the general principles in the various lipid guidelines.
  • Implement evidence-based recommendations for non-pharmacologic and pharmacologic lipid therapies in MetS.
  • Assess recent evidence for lipid intervention beyond statins.

Pre-registration is required. Please log in to register.

Additional information
Schedule: 

6:00 p.m. ♦ Lecture

7:30 p.m. ♦ Adjourn

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Florida Board of Laboratory Personnel
  • 1.50 Florida Board of Nursing
  • 1.50 Nurse Practitioners
  • 1.50 Florida Board of Respiratory Therapy
  • 1.50 General certificate of attendance
Course opens: 
01/10/2017
Course expires: 
03/31/2017
Event starts: 
02/15/2017 - 6:00pm
Event ends: 
02/15/2017 - 7:30pm
Baptist Hospital of Miami
8900 N. Kendall Drive
5MCVI
Miami, FL 33176
United States

Carl "Chip" Lavie M.D., FACC, FESPM
Medical Director, Cardiac Rehabilitation and Prevention
Director, Exercise Laboratories
John Ochsner Heart and Vascular Institute
Professor of Medicine
Ochsner Clinical School-UQ School of Medicine
Editor-in-Chief, Progress in Cardiovascular Diseases
Associate Editor and Cardiovascular Section Editor,Mayo Clinic Proceedings

Carl Lavie, M.D. has indicated he is a consultant and is a member of the speakers’ bureau for Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, Amgen, Sanofi, Regeneron, Amarin Pharma, Upsher Smith, Kowa Pharma, DSM and his discussion will not include mention of investigational or off-label usage.

Non-faculty contributors and other individuals involved in the planning, development, review and editing of the symposium content have indicated neither they nor their spouses/partners have relevant financial relationships.

Disclosure Policy and Disclaimer

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Florida Board of Laboratory Personnel
  • 1.50 Florida Board of Nursing
  • 1.50 Nurse Practitioners
  • 1.50 Florida Board of Respiratory Therapy
  • 1.50 General certificate of attendance

Accreditation Period

Course opens: 
01/10/2017
Course expires: 
03/31/2017
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
Please login or register to take this course.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support